Navigation Links
Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
Date:9/8/2009

Practices (GCP) guidelines.

The World Health Organization reports that breast cancer is the most commonly diagnosed cancer in women and is second only to lung cancer as a leading cause of female cancer deaths. The National Cancer Institute estimates that approximately 192,370 U.S. women will be diagnosed with breast cancer in 2009 and 40,170 women will die of the disease in the U.S. alone.

Bavituximab is a monoclonal antibody that targets the cellular membrane component phosphatidylserine (PS) that is usually located inside cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. By masking PS, bavituximab is believed to help mobilize the body's immune system to destroy the tumor and the tumor blood vessels. Bavituximab is being tested in combination with chemotherapy in Phase II trials in advanced lung cancer and advanced breast cancer. Interim results in these trials were encouraging, with objective tumor response rates that compare favorably to chemotherapy alone.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara((R)). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregri
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
6. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
7. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... revamped website from Cleveland-based Life Line Screening allows users to ... screening, learn what to expect at a health screening, share ... Facebook, Twitter, and YouTube. The health screening company’s ... , ... Cleveland, OH (PRWEB) December ...
(Date:12/17/2009)... size distribution technologies, including the new C35 Atex, at the ... , ... (PRWEB) December 17, 2009 -- ... of Pharmaceutical Scientists’ Annual Meeting, AAPS 2010 , in New ... AAPS 2010 to see the latest particle size distribution technologies ...
(Date:12/16/2009)... has passed as fact among historians, journalists and politicians, ... the floor of the U.S. Congress: British forces used ... , But that claim has never been fully ... a historian at Colgate University. According to Douglas,s research, ... of Modern History , no such incident ever occurred. ...
(Date:12/16/2009)... East Anglia (UEA) could contribute to the development of ... clean electricity. , Published today by the leading scientific ... (PNAS), the researchers have demonstrated for the first ... ,breathing rocks,. , The findings could be applied to ... as fuel cells, or ,bio-batteries, powered by animal or ...
Breaking Biology Technology:Website Redesign Enhances Global Health Screening Service's Online Presence 2Website Redesign Enhances Global Health Screening Service's Online Presence 3Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4'Rock-breathing' bacteria could generate electricity and clean up oil spills 2
... MIDDLETON, Mass., Sept. 25 We are very ... of NeuroTherm, Inc.,Outstanding customer service, product reliability, and ... the new company resulting,in a more powerful union ... education and product development. In 1980 Cotop ...
... Austria, September 25 f-star, an antibody,engineering ... on its unique Modular Antibody Technology, today ... Chief Scientific Officer. Dr. Mudde has,over 20 ... pharmaceutical industry,specializing in preclinical research and development. ...
... Testing Process Says ... American College of Medical Genetics, BETHESDA, Md., Sept. 25 ... home DNA test kits, tests that can,help determine a person,s ... greater availability of genetic tests and,increased Direct-to-Consumer (DTC) advertising, however, ...
Other Biology Technology:Antibody Engineering Company f-Star Appoints Geert Mudde as Chief Scientific Officer 2Statement on Direct-To-Consumer Genetic Testing 2Statement on Direct-To-Consumer Genetic Testing 3
(Date:12/16/2009)... drop of water is a high priority for grape growers in ... vines have to be irrigated to make it through the growing ... the water applied to the vines zips right by the plants, ... of the water that is applied is lost below the vine ... vine roots," said Eve Hinckley, who worked on the project for ...
(Date:12/16/2009)... determined that short-term, seasonal exposure to pesticides in ... size of wild salmon populations. In addition to ... suggest that exposure to commonly used pesticides may ... populations. , "Major efforts are currently underway ... to recover depressed populations," says David Baldwin of ...
(Date:12/16/2009)... 1 iQor, a global provider of business ... InfoWorld 100 Awards Top 100 IT project ... was the first submission for iQor. ,, "We are ... companies," said Vikas Kapoor, president and CEO of iQor. ... allowing us to work faster, smarter and with the ...
Breaking Biology News(10 mins):Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2SDA Introduces Cleaning101 on Twitter 50426 1SDA Introduces Cleaning101 on Twitter 50426 2Availity Announces Strategic Relationship With Anthem Blue Cross and Blue Shield in Kentucky 50423 1Availity Announces Strategic Relationship With Anthem Blue Cross and Blue Shield in Kentucky 50423 2Availity Announces Strategic Relationship With Anthem Blue Cross and Blue Shield in Kentucky 50423 3ICA CDS Team Up to Offer Solution That Aggregates Patient Information 50420 1ICA CDS Team Up to Offer Solution That Aggregates Patient Information 50420 2ICA CDS Team Up to Offer Solution That Aggregates Patient Information 50420 3
... first neuroimaging study to examine motor execution in children ... uncovered important new insight into the neurological basis of ... Brain ,s April 23 Brain Advanced Access, compared the ... their typically developing peers while performing a simple motor ...
... on the surface of Madagascar hissing cockroaches help decrease ... cockroaches, bodies, potentially reducing allergic responses among humans who ... Scientists cultured and identified fungi on the cockroaches, body ... presence of these mites reduced the molds by at ...
... to infection between men and women may explain higher ... community-acquired pneumonia (CAP). The findings, published online in the ... implications for understanding sex differences in life expectancy. , ... likely to survive after an infection compared to women ...
Other Biology News:First neuroimaging study examining motor execution in children with autism reveals new insights 2First neuroimaging study examining motor execution in children with autism reveals new insights 3Mites on hissing coackroach may benefit humans with allergies 2Mites on hissing coackroach may benefit humans with allergies 3Older men more likely than women to die after pneumonia 2Older men more likely than women to die after pneumonia 3
... depth • Reusable, press-to-seal gasket and cover ... and disassembled for hybridizing and imaging thick ... with up to a 13 mm diameter. ... Minimize specimen handling, eliminate evaporation and leaking ...
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
...
... Features A direct, ... molecules to the well surface ... , Maleic anhydride maintains its ... for months under dry, room ...
Biology Products: